Jun 2026
Investor Update
Kihealth opens Series A financing round
Accredited investors invited to participate in the company's foundational growth round supporting platform expansion.
Investor News
News, milestones, and
investor updates.
Company announcements, partnerships, scientific publications, awards, and updates for the Kihealth investor community.
May 2026
Milestone
InterceptIQ™ platform achieves 100,000 longitudinal samples
A foundational dataset milestone enabling next-generation predictive models across disease verticals.
Apr 2026
Partnership
Strategic collaboration with leading academic medical center
Multi-year research agreement expanding access to longitudinal patient cohorts and clinical validation infrastructure.
Mar 2026
Press Release
BetaIntercept™ T1 enrolls 4,000th participant in validation study
Pivotal multi-site validation reaches a major recruitment milestone ahead of regulatory submission.
Feb 2026
Publication
Methylation atlas published in peer-reviewed journal
Tissue-of-origin resolution at 47 cell types — establishing a new scientific baseline for liquid biopsy.
Jan 2026
Award
Recognized as 'Most Promising Platform Company' at industry summit
Independent industry recognition of the InterceptIQ™ platform's strategic position in molecular intelligence.
Dec 2025
Milestone
Kihealth Europe operational footprint established
European clinical and commercial operations launch in support of cross-border platform deployment.
Nov 2025
Press Release
FDA Breakthrough Device designation for OncoIntercept™
Designation accelerates the development and review path for early pancreatic cancer detection.
For media inquiries, contact our communications team.
Media Inquiries